Form 4: Geron Corp Executive James Ziegler Acquires 1,600,000 Stock Options
SEC Form 4 Filing
EVP, Chief Commercial Officer of Geron Corporation, James Ziegler, reports the acquisition of 1,600,000 stock options.
Summary
- On September 9, 2024, James Ziegler, EVP, Chief Commercial Officer of Geron Corporation, acquired 1,600,000 stock options with an exercise price of $4.41.
- The options vest in installments, starting with 200,000 shares on March 9, 2025, and the remaining 1,400,000 shares vesting monthly over 42 months, contingent upon continued service to the company.
- The expiration date for these options is September 8, 2034.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine filing related to executive compensation. The acquisition of stock options can be seen as a positive sign, but it's not a major event.
Positives
- The acquisition of stock options by a key executive could signal confidence in the company's future performance.
Future Outlook
The vesting schedule is contingent upon the optionee's continued service to the company.
Industry Context
Stock option grants are a common form of executive compensation in the biotechnology industry, aligning management's interests with those of shareholders.
Stakeholder Impact
- The stock option grant aligns the executive's interests with those of the shareholders.
Key Dates
| Date | Description |
|---|---|
| 09/09/2024 | Date of transaction: James Ziegler acquired 1,600,000 stock options. |
| 03/09/2025 | First vesting date: 200,000 shares vest. |
| 09/08/2034 | Expiration date of the stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.